Clinical Trial: Retro-Prospective Postmarket Clinical Study For FX Shoulder Solutions Long Cemented HUMELOCK II(R)

U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07663552) titled 'Retro-Prospective Postmarket Clinical Study For FX Shoulder Solutions Long Cemented HUMELOCK II(R)' on June 17.

Brief Summary: This study takes place in the framework of the PostMarket Clinical Follow-up plan of the HUMELOCK II(r) long cemented humeral stem (shoulder prosthesis) commercialized by FX SHOULDER SOLUTIONS.

The included cases will be followed for 10 years after index surgery. Primary objective is the assessment in real life of the revision rate of the shoulder systems at long-term.

Secondary objectives are

* Revision rate at each post op visit

* Range of motion at each post op visit

* Constant Score, American Should...